Computational Pathology Market By Component (Hardware, Software, Services), By Application (Oncology, Infectious Diseases, Genetic & Rare Disorders, Drug Discovery & Development, Immunology & Autoimmune Diseases, Neurological Disorders, Others), By Technology (Whole-Slide Imaging, Telepathology, AI-based Diagnostics, Digital Staining & Quantification Tools, Others), By End-User (Hospitals & Clinics, Diagnostic Laboratories, Research Institutes & Academic Centers, Pharmaceutical & Biotech Companies, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Published Date: Sep 2025 | Report ID: MI3642 | 217 Pages


Report Coverage:

By Component

  • Hardware
  • Software
  • Services

By Application

  • Oncology
  • Infectious Diseases
  • Genetic & Rare Disorders
  • Drug Discovery & Development
  • Immunology & Autoimmune Diseases
  • Neurological Disorders
  • Others

By Technology

  • Whole-Slide Imaging (WSI)
  • Telepathology
  • AI-based Diagnostics
  • Digital Staining & Quantification Tools
  • Others

By End-User

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Research Institutes & Academic Centers
  • Pharmaceutical & Biotech Companies
  • Others

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

List of Companies:

  • PathAI
  • Paige
  • Ibex Medical Analytics
  • Visiopharm
  • Proscia
  • Leica Biosystems
  • Philips Healthcare
  • Roche
  • F. Hoffmann-La Roche Ltd.
  • Hamamatsu Photonics
  • Olympus Corporation
  • Tempus
  • Epredia
  • Nucleai
  • Aiforia Technologies

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.